The EU is set to announce significant changes to post-Brexit regulations that will allow medicines to continue to flow between Britain and Northern Ireland.
The move signals welcome progress in difficult and complex negotiations about the implications for Northern Ireland amid the UK’s departure from the EU.
As part of Brexit, Northern Ireland remains in the EU’s Single Market for goods, including pharmaceutical regulations.
This is to avoid a hard border between UK province Northern Ireland and the Republic of Ireland, which remains part of the EU.
Some fear the re-emergence of border infrastructure between the two would see a return to the sectarian violence that blighted the region for decades.
Yet problems were foreseen, prompting
Read more on euronews.com